By Maggie Salinger, MD, MPP, and Arif Kamal, MD MBA, MHS, FAAHPM, FASCO Posted: December 11, 2019 IN REFERENCE TO: Mor V, Wagner TH, Levy C, et al. Association of […] Read more
PROVIDER RESOURCES
MARIPOSA OS Data Confirms Improved Efficacy for Amivantamab Plus Lazertinib in the First Line for EGFR-mutated NSCLC
INDUSTRY SUPPORTED
COCOON’s Prophylactic Regimen Resulted in Decreased Incidence and Severity of Dermatologic-related Adverse Events